Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus

Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: TQ-F3083 capsule 5 mg;   Drug: TQ-F3083 capsule 10 mg;   Drug: TQ-F3083 blank analog capsule;   Drug: Linagliptin blank analog tablet;   Drug: Linagliptin tablet Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials